Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

4 clinical studies listed.

Filters:

Primary Molar Pulpotomy

Tundra lists 4 Primary Molar Pulpotomy clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT07876934

Effect of Hemostatic Agents on TheraCal PT Pulpotomy Success in Primary Molars

Dental caries in primary teeth can sometimes lead to inflammation of the dental pulp, the soft tissue inside the tooth. When the pulp remains capable of healing, pulpotomy may be performed to preserve the tooth until its natural exfoliation. During this procedure, bleeding from the remaining pulp tissue must be controlled before a pulp dressing material is placed. This randomized controlled clinical trial aims to compare the clinical and radiographic success of TheraCal PT pulpotomy in primary molars when three different solutions are used to control bleeding: 2.5% sodium hypochlorite, 15% ferric sulfate, and normal saline. Children aged 4-6 years who have primary molars diagnosed with reversible pulpitis and meet the study's eligibility criteria will be enrolled. Participants will be randomly assigned to one of three groups according to the hemostatic solution used during the pulpotomy procedure. TheraCal PT will be used as the pulpotomy material in all three groups. The treated teeth will be evaluated clinically at 3, 6, 9, and 12 months and radiographically at baseline, 6 months, and 12 months. The researchers will compare the outcomes among the three groups to determine whether the choice of hemostatic solution affects the success of TheraCal PT pulpotomy in primary molars. The findings may help improve understanding of the role of different hemostatic solutions in pulpotomy treatment for primary teeth.

Gender: All

Ages: 4 Years - 6 Years

Updated: 2026-10-15

1 state

Reversible Pulpitis
Dental Caries
Primary Molar Pulpotomy
+1
COMPLETED

NCT07769697

Comparative Clinical and Radiographic Evaluation of Different Pulpotomy Materials in Primary Molars

This randomized clinical trial compared the clinical and radiographic outcomes of ferric sulfate (FS), mineral trioxide aggregate (MTA), calcium-enriched mixture (CEM), and TheraCal PT used for pulpotomy in primary molars. A total of 140 restorable primary molars from children aged 4 to 9 years were randomly allocated to four treatment groups. Clinical and radiographic evaluations were performed at 3, 6, 9, and 12 months to compare treatment success and failure among the four pulpotomy materials.

Gender: All

Ages: 4 Years - 9 Years

Updated: 2026-08-18

1 state

Dental Caries
Pulp Exposure, Dental
Primary Teeth
+1
NOT YET RECRUITING

NCT07675330

Oxymetazoline Versus Sodium Hypochlorite as Hemostatic Agents in MTA Pulpotomy of Primary Molars

This study aims to evaluate clinical and radiographic success of oxymetazoline versus sodium hypochlorite as hemostatic agents in MTA pulpotomy of primary molars.

Gender: All

Ages: 4 Years - 8 Years

Updated: 2026-06-30

Pulp Disease, Dental
Pulp Therapy in Primary Molars
Pulpitis - Reversible
+5
RECRUITING

NCT04902495

Clinical and Radiographic Evaluation of Pulpotomies in Primary Molars Using Tricalcium Silicate Cements

The objective of the study is to evaluate the success rate of pulpotomies in temporary molars using different types of hemostats and pulp coating materials based on tricalcium silicates, in patients who have attended the Dental Clinic of the International University of Catalonia (UIC).

Gender: All

Ages: 4 Years - 9 Years

Updated: 2024-04-05

1 state

Primary Molar Pulpotomy